Clinical Trial Update: The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

This clinical trial update outlines a Phase 3 study of JMT101 in combination with irinotecan as a ≥3rd-line treatment for metastatic colorectal cancer, with rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• JMT101

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: Metastatic Colorectal Cancer (mCRC) | Phase 3 | Status: NOT_YET_RECRUITING